Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022 https://ift.tt/eA8V8J

The Phase-2 study will be conducted in 400 healthy subjects while Phase III part of the study will enroll 4000 healthy subjects who are 18 years and above upto 80 years.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3ENyoq0
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.